Document Detail


Long-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients.
MedLine Citation:
PMID:  23425544     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Aims: The optimal drug-eluting stent (DES) in ST-elevation myocardial infarction (STEMI) patients remains unclear. We sought to compare the long-term performance of everolimus-eluting stents (EES) and Endeavor zotarolimus-eluting stents (E-ZES) in STEMI. Methods and results: The current analysis of a prospective registry included consecutive patients treated with EES or E-ZES for STEMI. Adjustment for measured confounders was done using Cox regression. In total, 931 patients met the inclusion criteria (412 EES and 519 E-ZES). Baseline characteristics were balanced, apart from a lower rate of renal insufficiency in EES. Median follow-up duration was 2.4 years (IQR 1.6-3.1). Mortality outcomes were similar. Up to three-year follow-up, the composite endpoint of cardiac death, target vessel-related myocardial infarction and target lesion revascularisation (TLR) was lower in EES; 9.7% vs. 13.7% in E-ZES (HR 0.64, 95% CI: 0.42-0.99), primarily driven by reduced TLR rates; 3.4% in EES vs. 7.3% in E-ZES (HR 0.46, 95% CI: 0.23-0.92). Definite stent thrombosis rates were low and similar between groups (1.1% in EES vs. 1.9% in E-ZES, p=0.190). Conclusions: Use of EES led to lower rates of the composite endpoint, driven by reduced TLR. This suggests that EES are more efficacious than Endeavor ZES in STEMI. Definite ST rates were low, and the strategy of second-generation DES implantation and the administration of upfront GP IIb/IIIa inhibitors appear to be safe in STEMI.
Authors:
Matthijs A Velders; Helèn Boden; Bas L van der Hoeven; Su-San Liem; Jaël Z Atary; Ernst E van der Wall; J Wouter Jukema; Martin J Schalij
Related Documents :
24386574 - Relationship of plasma adiponectin levels with acute coronary syndromes and coronary le...
24922884 - 91 differentiating physiological left ventricular hypertrophy from hypertrophic cardi...
23121324 - Compelling evidence for coronary-bypass surgery in patients with diabetes.
24419804 - Reperfusion therapy for st elevation acute myocardial infarction 2010/2011: current sta...
6714214 - Three cases of ruptured mitral valve chordae in the horse.
16935724 - Cardiac motion analysis to improve pacing site selection in crt.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  8     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-02-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  1199-206     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing managem...
Next Document:  Immediate vs. delayed stenting in acute myocardial infarction: a systematic review and meta-analysis...